Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Activated leukocyte cell adhesion molecule (ALCAM) is a marker of recurrence and promotes cell migration, invasion, and metastasis in early-stage endometrioid endometrial cancer.

Autor: Devis L; Biomedical Research Group in Gynecology, Vall Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain., Moiola CP; Biomedical Research Group in Gynecology, Vall Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain., Masia N; Cell Cycle and Ovarian Cancer Group, Biomedical Research Group in Gynecology, Vall Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain., Martinez-Garcia E; Biomedical Research Group in Gynecology, Vall Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain., Santacana M; Pathological Oncology Group and Pathology Department, Hospital Arnau de Vilanova, Lleida, Spain., Stirbat TV; Institut Curie, CNRS, UMR168, Paris, France., Brochard-Wyart F; Institut Curie, CNRS, UMR168, Paris, France., García Á; Pathology Department, Vall Hebron University Hospital, Barcelona, Spain., Alameda F; Pathology Department, Hospital del Mar, Barcelona, Spain., Cabrera S; Gynecological Oncology Department, Vall Hebron University Hospital, Barcelona, Spain., Palacios J; Department of Pathology, Hospital Universitario Ramón y Cajal, 28031 Madrid, Spain., Moreno-Bueno G; Hospital MD Anderson Cancer Centre Madrid, 28033 Madrid, Spain.; Departament of Biochemistry, Universidad Autonoma de Madrid (UAM), Instituto de Investigaciones Biomedicas 'Alberto Sols' (CSIC-UAM), IdiPAZ, 28046 Madrid, Spain., Abal M; Translational Medical Oncology, Health Research Institute of Santiago (IDIS), Fundacion Ramon Dominguez, SERGAS, 15706 Santiago de Compostela, Spain., Thomas W; Department of Natural Sciences, Colby-Sawyer College, New London, NH 03257, USA., Dufour S; Institut Curie, CNRS, UMR144, Paris, France., Matias-Guiu X; Pathological Oncology Group and Pathology Department, Hospital Arnau de Vilanova, Lleida, Spain., Santamaria A; Cell Cycle and Ovarian Cancer Group, Biomedical Research Group in Gynecology, Vall Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain., Reventos J; Biomedical Research Group in Gynecology, Vall Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.; Basic Sciences Department, International University of Catalonia, Barcelona, Spain., Gil-Moreno A; Biomedical Research Group in Gynecology, Vall Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.; Gynecological Oncology Department, Vall Hebron University Hospital, Barcelona, Spain., Colas E; Biomedical Research Group in Gynecology, Vall Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.; Pathological Oncology Group and Pathology Department, Hospital Arnau de Vilanova, Lleida, Spain.

Publikováno v: The Journal of pathology [J Pathol] 2017 Mar; Vol. 241 (4), pp. 475-487. Date of Electronic Publication: 2017 Jan 23.